This report studies External Cardiac Pacemakers market.
Temporary cardiac pacing is an intervention that helps the heartbeat get back to a normal pace if it has been temporarily out of rhythm.
In temporary cardiac pacing, wires are inserted through the chest (during heart surgery), or a large vein in the groin or neck, and are directly connected to the heart. These wires are connected to an external pacing box, which delivers a current to the heart to make it beat normally.
Temporary cardiac pacing can be used for days or weeks. But if there are long-term problems with the rhythm of your heartbeat, then a permanent pacemaker may be needed. This is a small pacing box that gets inserted inside the chest.
Due to the COVID-19 pandemic, the global External Cardiac Pacemakers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe External Cardiac Pacemakers market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe External Cardiac Pacemakers landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Single Chamber Pacemakers accounting for % of the External Cardiac Pacemakers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Bradycardia segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of External Cardiac Pacemakers include Medtronic, Abbott (St. Jude Medical), Boston Scientific, Biotronik, Oscor, Osypka AG, MicroPort (Sorin), Lepu Medical (Qinming Medical) and Pacetronix and etc. In terms of revenue, the global 3 largest players have a % market share of External Cardiac Pacemakers in 2021.
This report focuses on External Cardiac Pacemakers volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall External Cardiac Pacemakers market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.
Global External Cardiac Pacemakers Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single Chamber Pacemakers
Dual Chamber Pacemakers
Segment by Application
Bradycardia
Atrial Fibrillation
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic
Abbott (St. Jude Medical)
Boston Scientific
Biotronik
Oscor
Osypka AG
MicroPort (Sorin)
Lepu Medical (Qinming Medical)
Pacetronix
Shenzhen Lifetech Cardio Medical Electronics